FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 83 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $85,000 | +39.3% | 10,292 | +0.5% | 0.01% | +20.0% |
| Q1 2022 | $61,000 | -51.2% | 10,236 | -11.6% | 0.01% | -44.4% |
| Q4 2021 | $125,000 | -51.2% | 11,580 | -16.9% | 0.01% | -50.0% |
| Q3 2021 | $256,000 | -62.0% | 13,939 | -50.9% | 0.02% | -28.0% |
| Q2 2021 | $674,000 | +64.4% | 28,364 | +90.0% | 0.02% | -26.5% |
| Q1 2021 | $410,000 | -35.7% | 14,925 | -8.8% | 0.03% | -43.3% |
| Q4 2020 | $638,000 | +126.2% | 16,370 | +161.0% | 0.06% | +81.8% |
| Q3 2020 | $282,000 | – | 6,272 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,529 | $43,866,000 | 8.09% |
| Logos Global Management LP | 1,410,000 | $39,508,000 | 3.86% |
| RA Capital Management | 9,011,651 | $252,506,000 | 3.81% |
| Cormorant Asset Management, LP | 4,720,000 | $132,254,000 | 2.95% |
| Artal Group S.A. | 1,000,000 | $28,020,000 | 0.50% |
| Perceptive Advisors | 1,250,000 | $35,025,000 | 0.44% |
| HighVista Strategies LLC | 20,630 | $578,000 | 0.43% |
| HHLR ADVISORS, LTD. | 1,100,000 | $30,822,000 | 0.30% |
| Baker Brothers Advisors | 2,024,876 | $56,737,000 | 0.25% |
| Tekla Capital Management LLC | 149,825 | $4,198,000 | 0.14% |